BioWorld - Tuesday, March 24, 2026

BioWorld Science

May 28, 2013

View Archived Issues

Ghrelin agonist tested in gastrointestinal symptoms related to Parkinson's disease

Read More

Global molecular signature for the prognosis of hepatocellular carcinoma identified

Read More

[11C]Cimbi-36 demonstrates utility for human brain imaging

Read More

Development of Sangamo BioSciences' ZFP beta-thalassemia treatment receives support

Read More

Novel pneumonia vaccine candidate induces systemic and mucosal immune response in vivo

Read More

In vivo results for a novel ApoC-II mimetic peptide reported

Read More

Oxford BioMedica develops a novel gene therapy for IOP

Read More

A novel PET tracer shows PDE10A specificity in rat and monkey striatum

Read More

Astellas Pharma will not seek European approval for tivozanib in RCC

Read More

Valeant Pharmaceuticals to acquire Bausch & Lomb

Read More

GSK and Tempero Pharmaceuticals jointly develop HDAC9 inhibitors

Read More

Recent Merck & Co. patents describe novel ROMK blockers

Read More

Novel nicotinic alpha4beta2 receptor ligands identified by Targacept

Read More

Italian researchers synthesize novel HSP 90 inhibitors

Read More

Vertex Pharmaceuticals discloses novel Na(v)1.7 blockers

Read More

Virobay begins phase I trial of oral pain treatment candidate VBY-036

Read More

PlantForm and PharmaPraxis collaborate on biosimilars/biobetters

Read More

Astellas' isavuconazole granted orphan drug status for invasive aspergillosis

Read More

Chembio awarded U.S. government contract to develop diagnostic tests

Read More

Eisai set to launch Inovelon tablets in Japan

Read More

4SC's Japanese partner Yakult Honsha begins phase I/II study of resminostat in liver cancer

Read More

Bayer's Xarelto approved in Europe for additional indication

Read More

AstraZeneca enters definitive agreement to acquire Omthera Pharmaceuticals

Read More